ABSTRACT
Chemicals are representative environmental factors that affect human health. Recently, external exposure to a chemical of rhododenol (RD) caused chemical leukoderma, an acquired patchy hypopigmentation, in about 20,000 Asian people. The development of a hazard assessment system for accurate determination of leukoderma-inducible chemicals is required for the prevention of such tragedies. Case studies in humans have shown 6 chemicals, including RD, with a constitutive leukoderma-inducible potency and 3 chemicals with a photosensitive but not a constitutive leukoderma-inducible potency. In this study, the 6 positive and 3 negative control chemicals with or without constitutive leukoderma-inducible potencies were investigated by our previously developed in vivo hazard assessment system using tail skin of mice. Based on the results of validation, this study aimed to develop an in vitro hazard assessment system to correctly determine chemicals with a constitutive leukoderma-inducible potency. As expected, external exposure to the 6 positive control chemicals, but not external exposure to the 3 negative control chemicals, resulted in development of constitutive leukoderma in mouse tail skin with a decreased level of skin melanin and decreased number of melanocytes. Moreover, the 6 positive and 3 negative control chemicals were correctly distinguished by the presence or absence of endoplasmic reticulum (ER) stress induction, but not by tyrosinase-dependent cell death or production of reactive oxygen species (ROS), in immortalized normal melanocytes. The hazard assessment system using tail skin could be a solid in vivo tool to reliably determine the chemical potency of a chemical for constitutive leukoderma induction. The hazard assessment system focusing on ER stress induction in normal melanocytes might be a novel and convenient in vitro tool for accurately evaluating chemicals with leukoderma-inducible potencies. Thus, this study contributed to environmentology through the development of a screening system for preventing an environmental factor-related disease.
Subject(s)
Hypopigmentation , Animals , Mice , Hypopigmentation/chemically induced , Risk Assessment , Melanocytes/drug effects , Skin/drug effects , Endoplasmic Reticulum Stress/drug effects , Melanins , Humans , Toxicity Tests/methods , ButanolsABSTRACT
Southern flounder skin pigmentation is a critical phenotypic characteristic for this species' survival in the natural environment. Normal pigmentation allows rapid changes of color for concealment to capture prey and UV light protection. In contrast, highly visible hypopigmented pseudo-albinos exhibit a compromised immune system and are vulnerable to predation, sensitive to UV exposure, and likely have poor survival in the wild. Skin and brain tissue samples from normally pigmented and hypopigmented individuals were analyzed with next-generation RNA sequencing. A total of 1,589,613 transcripts were used to identify 952,825 genes to assemble a de novo transcriptome, with 99.43% of genes mapped to the assembly. Differential gene expression and gene enrichment analysis of contrasting tissues and phenotypes revealed that pseudo-albino individuals appeared more susceptible to environmental stress, UV light exposure, hypoxia, and osmotic stress. The pseudo-albinos' restricted immune response showed upregulated genes linked to cancer development, signaling and response, skin tissue formation, regeneration, and healing. The data indicate that a modified skin collagen structure likely affects melanocyte differentiation and distribution, generating the pseudo-albino phenotype. In addition, the comparison of the brain transcriptome revealed changes in myelination and melanocyte stem cell activity, which may indicate modified brain function, reduced melanocyte migration, and impaired vision.
Subject(s)
Brain , Flounder , Hypopigmentation , Skin Pigmentation , Skin , Transcriptome , Animals , Brain/metabolism , Brain/pathology , Skin/metabolism , Skin/pathology , Hypopigmentation/genetics , Flounder/genetics , Skin Pigmentation/genetics , Gene Expression Profiling , Ultraviolet Rays/adverse effectsSubject(s)
Hypopigmentation , Humans , Hypopigmentation/pathology , Piebaldism/pathology , Piebaldism/complications , Female , MaleABSTRACT
A patient had bilateral leg edema, insomnia, myalgias, paresthesias in the fingertips, lighter pigmentation of the facial skin compared with other areas of the body, proteinuria, and an elevated creatinine level. What is the diagnosis and what would you do next?
Subject(s)
Myalgia , Proteinuria , Humans , Proteinuria/etiology , Myalgia/etiology , Male , Face , Female , Diagnosis, Differential , Middle Aged , Hypopigmentation/etiology , Skin PigmentationSubject(s)
Cicatrix, Hypertrophic , Hyperpigmentation , Hypopigmentation , Humans , Cicatrix, Hypertrophic/pathology , Cicatrix, Hypertrophic/therapy , Cicatrix, Hypertrophic/etiology , Hypopigmentation/etiology , Hypopigmentation/pathology , Hyperpigmentation/etiology , Hyperpigmentation/pathology , Female , Intense Pulsed Light Therapy/methods , Male , Adult , Treatment Outcome , Child , Adolescent , InflammationABSTRACT
Diffuse hyperpigmentation with guttate hypopigmentation (DHGH) is a new acquired pigmentary disorder. Only a few cases have previously been reported in the Chinese population, in Chinese. To summarise the clinical, dermoscopic, and histopathological findings of DHGH in the English literature, to improve the recognition and management of this condition. This was a retrospective study to summarise the clinical, dermoscopic, and pathological findings of nine cases of DHGH. All nine patients with DHGH were female. The age at onset varied from 6 to 24 years (median 17 years). Patients were generally in good health without systemic disease. The lesions were often generalised to the trunk and extremities without any discomfort. Typical lesions were characterised by multiple uniform hypopigmented spots, 2-5 mm in diameter, irregularly distributed over diffuse hyperpigmentation. Dermoscopy revealed multiple blurred patchy areas of brownish pigmentation, sparse linear and dotted vessels, and perifollicular pigmentation on a white to bright white background, surrounded by brown hyperpigmentation. Histopathological findings included mild abnormal pigment of the epidermis, focal vacuolar degeneration of the basal cells, mild pigment incontinence and perivascular lymphocytic infiltration in the dermis. DHGH is a new entity with distinctive clinical manifestations that differ from those of other known pigmentary disorders. So far, DHGH has only been reported in the Chinese population. It may not be uncommon and has not received much attention due to the few reports. The aetiology and pathogenesis of DHGH are still unknown and require further investigation.
Subject(s)
Hyperpigmentation , Hypopigmentation , Humans , Female , Hyperpigmentation/pathology , Hypopigmentation/pathology , Retrospective Studies , Adolescent , Young Adult , Child , Dermoscopy , AdultSubject(s)
Hypopigmentation , Humans , Hypopigmentation/pathology , Skin Pigmentation , Male , FemaleSubject(s)
Ammonium Sulfate , Dermatitis, Allergic Contact , Hair Dyes , Hypopigmentation , Humans , Hair Dyes/adverse effects , Dermatitis, Allergic Contact/etiology , Dermatitis, Allergic Contact/diagnosis , Female , Ammonium Sulfate/adverse effects , Hypopigmentation/chemically induced , Adult , Patch TestsABSTRACT
Epidermal melanin unit integrity is crucial for skin homeostasis and pigmentation. Epidermal growth factor (EGF) receptor (EGFR) is a pivotal player in cell growth, wound healing, and maintaining skin homeostasis. However, its influence on skin pigmentation is relatively unexplored. This study investigates the impact and underlying mechanisms of EGFR inhibitors on skin pigmentation. We evaluated EGF and EGFR expression in various skin cells using quantitative real-time PCR, Western blot, and immunofluorescence. EGF and EGFR were predominantly expressed in epidermal keratinocytes, and treatment with the EGFR tyrosine kinase inhibitors (EGFR-TKIs) gefitinib and PD153035 significantly increased stem cell factor (SCF) and endothelin-1 (ET-1) expression in cultured keratinocytes. Enhanced melanocyte migration and proliferation were observed in co-culture, as evidenced by time-lapse live imaging and single-cell tracking assays. Furthermore, topical application of gefitinib to guinea pig dorsal skin induced increased pigmentation and demonstrated efficacy in mitigating rhododendrol-induced leukoderma. Suppression of EGF signaling indirectly enhanced skin pigmentation by upregulating SCF and ET-1 in epidermal keratinocytes. This novel mechanism highlights the pivotal role of EGF signaling in regulating skin pigmentation, and topical EGFR-TKI therapy at an appropriate dose may be a promising approach for depigmentation disorder management.
Subject(s)
ErbB Receptors , Gefitinib , Hypopigmentation , Keratinocytes , Melanins , Melanocytes , Protein Kinase Inhibitors , ErbB Receptors/metabolism , Animals , Melanins/metabolism , Melanins/biosynthesis , Humans , Protein Kinase Inhibitors/pharmacology , Melanocytes/drug effects , Melanocytes/metabolism , Melanocytes/pathology , Keratinocytes/drug effects , Keratinocytes/metabolism , Keratinocytes/pathology , Hypopigmentation/pathology , Hypopigmentation/drug therapy , Gefitinib/pharmacology , Guinea Pigs , Skin Pigmentation/drug effects , Stem Cell Factor/metabolism , Epidermis/drug effects , Epidermis/pathology , Epidermis/metabolism , Cell Proliferation/drug effects , Cell Movement/drug effects , Endothelin-1/metabolism , Epidermal Growth Factor/metabolism , Epidermal Growth Factor/pharmacology , QuinazolinesABSTRACT
Chemical leukoderma, or chemical-based vitiligo, is a dermal disease triggered by exposure to chemicals and characterized by the emergence of depigmentation or hypopigmentation of the skin. The etiology of this condition is associated with exposure to various chemical substances present in both occupational and non-occupational settings. The precise mechanism that underlies chemical leukoderma remains elusive and is believed to result from the demise of melanocytes, which are responsible for producing skin pigments. This condition has gained particular prominence in developing countries like India. An interesting connection between chemical leukoderma and vitiligo has been identified; studies suggest that exposure to many household chemicals, which are derivatives of phenols and catechol, may serve as a primary etiological factor for the condition. Similar to autoimmune diseases, its pathogenesis involves contributions from both genetic and environmental factors. Furthermore, over the last few decades, various studies have demonstrated that exposure to chemicals plays a crucial role in initiating and progressing chemical leukoderma, including cases stemming from occupational exposure.
Subject(s)
Occupational Exposure , Vitiligo , Humans , Vitiligo/chemically induced , Vitiligo/physiopathology , Occupational Exposure/adverse effects , Melanocytes/drug effects , India , Hypopigmentation/chemically induced , Environmental Exposure/adverse effectsABSTRACT
BACKGROUND: Syphilis is an infection caused by the bacteria Treponema pallidum. It is mainly transmitted through oral, vaginal and anal sex, in pregnancy and through blood transfusion. Syphilis develops in primary, secondary, latent and tertiary stages and presents with different clinical features at each stage. Infected patients can remain asymptomatic for several years and, without treatment, can, in extreme cases, manifest as damage in several organs and tissues, including the brain, nervous tissue, eyes, ear and soft tissues. In countries with a high human immunodeficiency virus (HIV) burden, syphilis increases the risk of HIV infections. We report the case of a young HIV-positive black woman who presented with alopecia and hypopigmentation as features of secondary syphilis. CASE PRESENTATION: A virologically suppressed 29-year-old woman on Anti-retroviral Therapy (ART) presented with a short history of generalized hair loss associated with a non-itchy maculopapular rash and skin depigmentation on the feet. Limited laboratory testing confirmed a diagnosis of secondary syphilis. She was treated with Benzathine Penicillin 2.4MU. After receiving three doses of the recommended treatment, the presenting features cleared, and the patient recovered fully. CONCLUSION: This case demonstrates the importance of a high index of clinical suspicion and testing for syphilis in patients presenting with atypical clinical features of secondary syphilis, such as hair loss and hypopigmentation. It also highlights the challenges in diagnosing and clinically managing syphilis in a resource-limited setting.
Subject(s)
HIV Infections , HIV Seropositivity , Hypopigmentation , Syphilis , Adult , Female , Humans , Alopecia/complications , HIV Infections/complications , HIV Infections/drug therapy , HIV Seropositivity/complications , Hypopigmentation/complications , Syphilis/complications , Syphilis/diagnosis , Syphilis/drug therapy , Black PeopleSubject(s)
Dermatitis, Allergic Contact , Patch Tests , Phenylenediamines , Humans , Phenylenediamines/adverse effects , Dermatitis, Allergic Contact/etiology , Dermatitis, Allergic Contact/diagnosis , Female , Coloring Agents/adverse effects , Scalp Dermatoses/chemically induced , Hypopigmentation/chemically induced , Male , Middle Aged , ScalpABSTRACT
The purpose of this paper is to expand on the phenotype of oculocutaneous albinism type 7 (OCA7). We described three patients with OCA7: two from a consanguineous family of Kurdish origin and one patient of Dutch origin. We compared them with all patients described to date in the literature. All newly described patients had severely reduced visual acuity (VA), nystagmus, hypopigmentation of the fundus, severe foveal hypoplasia, and chiasmal misrouting. None had iris translucency. All patients had normal pigmentation of skin and hair. We found one novel mutation in the Dutch patient: c.565G > A; p.(Gly189Ser). We compared our patients to the 15 described in the literature to date. All 18 patients had substantially pigmented skin and hair, very poor VA (0.4-1.3 logMAR), nystagmus, (mild) ocular hypopigmentation, foveal hypoplasia, and misrouting. Although pigmentation levels were mildly affected in OCA7, patients had a severe ocular phenotype with VA at the poorer end of the albinism spectrum, severe foveal hypoplasia, and chiasmal misrouting. OCA7 patients had a phenotype restricted to the eyes, and similar to that of X-linked ocular albinism. We therefore propose to rename the disorder in ocular albinism type 2. Unfolding the role of LRMDA in OCA7, may bring us a step closer in identifying the responsible factors for the co-occurrence of foveal hypoplasia and misrouting.
Subject(s)
Albinism, Ocular , Albinism, Oculocutaneous , Hypopigmentation , Nystagmus, Pathologic , Humans , Albinism, Ocular/diagnosis , Albinism, Ocular/genetics , Albinism, Oculocutaneous/diagnosis , Albinism, Oculocutaneous/genetics , Retina , Mutation , Vision DisordersSubject(s)
Hypopigmentation , Osteoporosis , Vitiligo , Humans , Vitiligo/epidemiology , Retrospective Studies , Osteoporosis/epidemiology , ComorbiditySubject(s)
Hypopigmentation , Mycosis Fungoides , Skin Neoplasms , Humans , Mycosis Fungoides/pathology , Mycosis Fungoides/diagnosis , Mycosis Fungoides/complications , Skin Neoplasms/pathology , Skin Neoplasms/diagnosis , Skin Neoplasms/complications , Hypopigmentation/pathology , Hypopigmentation/diagnosis , Male , Skin/pathology , FemaleABSTRACT
Vitiligo is an autoimmune skin disease of multiple etiology, for which there is no complete cure. This chronic depigmentation is characterized by epidermal melanocyte loss, and causes disfigurement and significant psychosocial distress. Mouse models have been extensively employed to further our understanding of complex disease mechanisms in vitiligo, as well as to provide a preclinical platform for clinical interventional research on potential treatment strategies in humans. The current mouse models can be categorized into three groups: spontaneous mouse models, induced mouse models, and transgenic mice. Despite their limitations, these models allow us to understand the pathology processes of vitiligo at molecule, cell, tissue, organ, and system levels, and have been used to test prospective drugs. In this review, we comprehensively evaluate existing murine systems of vitiligo and elucidate their respective characteristics, aiming to offer a panorama for researchers to select the appropriate mouse models for their study.